Stocks and Investing Stocks and Investing
Wed, April 10, 2024

Swayampakula Ramakanth Reiterated (ALXO) at Strong Buy and Held Target at $20 on, Apr 10th, 2024


Published on 2024-10-28 10:15:13 - WOPRAI, Swayampakula Ramakanth
  Print publication without navigation


Swayampakula Ramakanth of HC Wainwright & Co., Reiterated "ALX Oncology Holdings Inc." (ALXO) at Strong Buy and Held Target at $20 on, Apr 10th, 2024.

Swayampakula has made no other calls on ALXO in the last 4 months.



There are 2 other peers that have a rating on ALXO. Out of the 2 peers that are also analyzing ALXO, 1 agrees with Swayampakula's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Bradley Canino of "Stifel" Downgraded from Strong Buy to Hold and Increased Target to $14 on, Friday, March 8th, 2024


This is the rating of the analyst that currently disagrees with Swayampakula


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $21 on, Friday, March 8th, 2024
Contributing Sources